Samuel12_1980

Samuel12_1980

Now above MA100 and MA50 very risky

Samuel12_1980

Such a difficult area.

Samuel12_1980

Very risky stock sabby management holding tight - Heavily short position on it But , Above MA9 - Short position might be on high pressure. Not for any suggestion, very very risky

Samuel12_1980

Bad movement today, unfortunately due to a "bad" annual finance report, personally I do think the management has taken a good decision with cost reduction for the next 2 years. Consolidation of R&D activities in one location (Israel). Positions and operations eliminated will also reduce overlapping R&D and G&A activities in Israel and the United States; A 35%...

Samuel12_1980

Still negative for Long. Bold Downtrend line is still dominant.

Samuel12_1980

One more option

Samuel12_1980

HOLON, Israel, Jan. 14, 2019 /PRNewswire/ -- Compugen Ltd. (CGEN), a clinical-stage cancer immunotherapy company and leader in predictive target discovery, today announced that its Phase 1 clinical trial evaluating COM701, a first-in-class therapeutic antibody targeting PVRIG, will be featured in a trial-in-progress poster at The ASCO-SITC Clinical Immuno-Oncology...

Samuel12_1980

Current state is above 6.5. W pattern is an option.

Samuel12_1980

Only and ONLY above 13.62

Samuel12_1980

Recent Highlights: 1. Can-Fite announced that due to patient survival, top-line results of the Namodenoson Phase II advanced liver cancer study were expected to be released in Q1 2019. The statistical plan for this trial requires that the primary efficacy analysis occurs when no more than 3 of the original 78 patients survive. it means, approximately 2 months for...

Samuel12_1980

Resist 108 (case breaking resist, next destination is 115) oscillators are currently positive. Good-luck to all.

Samuel12_1980

Recognizing trending changes. Might be correction for short term. Entered today for long. Stop 2.3